Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHP

Kaylyn Collette, Cassandra L. Perkey, Val Adams, Brent J. Shelton, Lauren S. Corum, Allison Butts

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHP'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry